000-19125
|
33-0336973
|
(Commission File No.)
|
(IRS Employer Identification No.)
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
99.1 |
Press Release dated June 18, 2018.
|
Ionis Pharmaceuticals, Inc.
|
||
Dated: June 19, 2018
|
By:
|
/s/ Patrick R. O’Neil
|
Patrick R. O’Neil
|
||
Senior Vice President, Legal, General
|
||
Counsel and Chief Compliance Officer
|
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